← Leaderboards
Luis M Rocha
Indiana University Indianapolis
$1,021,469
Attributed
$3,064,406
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $483.2K · FY2014–21$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,064,406 · 2
By mechanism
R01$3,064,406 · 2
Top collaborators
- Katy Borner4 shared
- Lang Li4 shared
- Wendy Renee Miller4 shared
- Hagit Shatkay4 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Kirill S Lobachev$2,850,754
- Wendy Renee Miller$1,326,534
- Hagit Shatkay$1,839,849
- Maria C Carrillo$19,827,813
- Sophia Wang$3,527,551
Others in their field
Top investigators on “Evidence Base”
- Chanza Baytop · Westat, Inc.$271,217,917
- Abhik Das · Research Triangle Institute$169,340,048
- Larry Arthur$145,316,000
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
- Praduman Jain · Vignet, Inc.$103,566,231
- Edward V Nunes · Columbia University Health Sciences$98,324,709
Research focus
Evidence BaseDesignSourceDrug InteractionsPharmacologyEvaluationMedicalLiteratureTextTerminologyPubmedPharmaceutical PreparationsBaseMiningAdverse EffectsBasic ScienceAffectAreaAnxietyAdvocateAchievementCellsCharacteristicsCase Study
Grant awards (8)
myAURA: Personalized Web Service for Epilepsy Management$299,259
R01 · FY2021 · LM · contact PI
myAURA: Personalized Web Service for Epilepsy Management$336,135
R01 · FY2020 · LM · contact PI
myAURA: Personalized Web Service for Epilepsy Management$336,441
R01 · FY2019 · LM · contact PI
myAURA: Personalized Web Service for Epilepsy Management$336,733
R01 · FY2018 · LM · contact PI
Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical$394,297
R01 · FY2017 · LM · contact PI
Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical$397,279
R01 · FY2016 · LM
Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical$481,051
R01 · FY2015 · LM
Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical$483,211
R01 · FY2014 · LM